Stifel reiterated coverage on Inogen with a new price target

11/8/21 9:46:37 AM ET

$INGN

Industrial Specialties

Health Care

Get the next $INGN alert in real time by email

Stifel reiterated coverage of Inogen with a rating of Hold and set a new price target of $40.00 from $70.00 previously

Get the next $INGN alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$INGN

Date	Price Target	Rating	Analyst
6/16/2025	$14.00	Buy	B. Riley Securities
5/22/2025	$12.00	Hold → Buy	Needham
2/15/2024		Mkt Perform → Outperform	William Blair
8/8/2023	$15.00 → $8.00	Overweight → Neutral	JP Morgan
7/14/2023		Buy → Hold	Needham
1/17/2023		Outperform → Mkt Perform	William Blair
12/9/2021	$47.00	Hold → Buy	Needham
11/8/2021	$70.00 → $40.00	Hold	Stifel

More analyst ratings

Stifel reiterated coverage on Inogen with a new price target

Chat with this insight

Recent Analyst Ratings for
$INGN

$INGN
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

B. Riley Securities initiated coverage on Inogen with a new price target

Inogen upgraded by Needham with a new price target

Inogen upgraded by William Blair

$INGN
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Boehnlein Glenn S was granted 30,612 shares, increasing direct ownership by 66% to 76,885 units (SEC Form 4)

Director Rider Heather D. was granted 30,612 shares, increasing direct ownership by 53% to 88,201 units (SEC Form 4)

Director Sahney Mira Kirti was granted 30,612 shares, increasing direct ownership by 336% to 39,724 units (SEC Form 4)

$INGN
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

EVP, CFO & Treasurer Bourque Michael J. was granted 48,225 shares, converted options into 25,000 shares, covered exercise/tax liability with 28,579 shares and bought $24,960 worth of shares (3,000 units at $8.32) (SEC Form 4)

CEO and President Smith Kevin Raymond Merrill was granted 55,475 shares, converted options into 28,333 shares, covered exercise/tax liability with 39,797 shares and bought $100,245 worth of shares (11,709 units at $8.56), increasing direct ownership by 383% to 70,274 units (SEC Form 4)

Stifel reiterated coverage on Inogen with a new price target

Chat with this insight

Recent Analyst Ratings for $INGN

$INGN Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

B. Riley Securities initiated coverage on Inogen with a new price target

Inogen upgraded by Needham with a new price target

Inogen upgraded by William Blair

$INGN Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Boehnlein Glenn S was granted 30,612 shares, increasing direct ownership by 66% to 76,885 units (SEC Form 4)

Director Rider Heather D. was granted 30,612 shares, increasing direct ownership by 53% to 88,201 units (SEC Form 4)

Director Sahney Mira Kirti was granted 30,612 shares, increasing direct ownership by 336% to 39,724 units (SEC Form 4)

$INGN Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

EVP, CFO & Treasurer Bourque Michael J. was granted 48,225 shares, converted options into 25,000 shares, covered exercise/tax liability with 28,579 shares and bought $24,960 worth of shares (3,000 units at $8.32) (SEC Form 4)

CEO and President Smith Kevin Raymond Merrill was granted 55,475 shares, converted options into 28,333 shares, covered exercise/tax liability with 39,797 shares and bought $100,245 worth of shares (11,709 units at $8.56), increasing direct ownership by 383% to 70,274 units (SEC Form 4)

Recent Analyst Ratings for
$INGN

$INGN
Analyst Ratings

$INGN
Insider Trading

$INGN
Insider Purchases